LENZ
LENZ Therapeutics Inc
3.60$
-4.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +25.0% | +260.0% | -44.4% | +150.0% | +44.0% | -47.2% | +557.9% | -2,741.6% | – | -0.9% | – | |
| – | +4.9% | +82.8% | +68.6% | +37.2% | -25.6% | +56.7% | +11.4% | +21.9% | +6.0% | +17.4% | +3.5% | – | |
| – | -47.9% | -402.4% | – | – | – | -189.2% | – | +270.9% | -109.5% | – | -432.9% | – | |
| – | -99.0% | -100.0% | – | +39.8% | -19.9% | -26.2% | +118.2% | +82.9% | -91.3% | -52.6% | -11.1% | – | |
| – | – | +18.6% | -646.6% | -36.8% | -80.9% | – | -102.2% | +946.6% | +1,972.7% | – | +13.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +236.4% | – | -101.2% | – | -99.8% | -17.0% | +60,100.0% | -97.7% | +20,404.2% | -100.0% | +2,721.4% | – | |
| – | – | – | -170.4% | – | – | – | +405.1% | -184.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.